Bonus BioGroup Receives Approval to Expand Phase-II Clinical Trials for its COVID-19 Treatment to Medical Centers Across Israel TEL AVIV, ISRAEL, Aug. 22, 2021 (GLOBE NEWSWIRE) -- Bonus BioGroup LTD or "the Company" (BONS.TA), an Israeli clinical-stage biotechnology company, has received official approval from the Israeli...